Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization
- PMID: 11292425
- DOI: 10.1016/s0002-9394(00)00813-8
Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization
Abstract
Purpose: To report a case of retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.
Methods: Case report. A 74-year-old woman with exudative age-related macular degeneration and classic subfoveal choroidal neovascularization RE underwent photodynamic therapy with verteporfin.
Results: Ophthalmoscopy and fluorescein angiography RE disclosed a retinal pigment epithelial tear in the area of photodynamic therapy.
Conclusion: This case presents the first report of a retinal pigment epithelial tear after photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
Similar articles
-
Acute retinal pigment epithelial tear after photodynamic therapy.Retina. 2001;21(6):661-5. doi: 10.1097/00006982-200112000-00017. Retina. 2001. PMID: 11756893 No abstract available.
-
Evolution of retinal pigment epithelium detachment after photodynamic therapy for choroidal neovascularization in age-related macular degeneration.Eur J Ophthalmol. 2006 May-Jun;16(3):491-4. doi: 10.1177/112067210601600325. Eur J Ophthalmol. 2006. PMID: 16761259
-
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.Am J Ophthalmol. 2001 May;131(5):541-60. doi: 10.1016/s0002-9394(01)00967-9. Am J Ophthalmol. 2001. PMID: 11336929 Clinical Trial.
-
Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.Retina. 2002 Feb;22(1):6-18. doi: 10.1097/00006982-200202000-00003. Retina. 2002. PMID: 11884872 Review.
-
Photodynamic therapy update.Curr Opin Ophthalmol. 2001 Jun;12(3):202-6. doi: 10.1097/00055735-200106000-00010. Curr Opin Ophthalmol. 2001. PMID: 11389347 Review.
Cited by
-
Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization.Graefes Arch Clin Exp Ophthalmol. 2005 Mar;243(3):198-203. doi: 10.1007/s00417-004-0959-y. Epub 2004 Jul 17. Graefes Arch Clin Exp Ophthalmol. 2005. PMID: 15258778
-
Serous retinal detachment following combined photodynamic therapy and intravitreal bevacizumab injection.Korean J Ophthalmol. 2009 Jun;23(2):124-6. doi: 10.3341/kjo.2009.23.2.124. Epub 2009 Jun 9. Korean J Ophthalmol. 2009. PMID: 19568365 Free PMC article.
-
Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.Nanotechnol Rev. 2018 Feb;7(1):95-122. doi: 10.1515/ntrev-2017-0154. Epub 2017 Dec 12. Nanotechnol Rev. 2018. PMID: 29404233 Free PMC article.
-
Retinal pigment epithelial tear after intravitreal bevacizumab injection for exudative age-related macular degeneration.Oman J Ophthalmol. 2014 May;7(2):104-6. doi: 10.4103/0974-620X.137178. Oman J Ophthalmol. 2014. PMID: 25136244 Free PMC article. No abstract available.
-
Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1225-7. doi: 10.1007/s00417-007-0536-2. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17287977
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
